Topiramate
NDC 27808-327, Topiramate, capsule, extended release, from Cranbury Pharmaceuticals, LLC.
- Product NDC
- 27808-327
- Status
- Listed
- Labeler
- Cranbury Pharmaceuticals, LLC
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218695
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/27808-327 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOPIRAMATE100 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 27808-327-01 | 27808032701 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27808-327-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/8d5f9f77-403e-432a-8dcb-7995c6947ae0
Use it
Look up 27808-327 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/27808-327 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 27808-327. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.